Press releases
-
ICON and DIA driving Insights to Action with DIA Live 2018
Social media aggregation site will highlight real-time digital conversations at DIA 2018
-
ICON enhances Endpoint Adjudication Services
Agreement to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality
-
ICON launches FIRECREST Financial Disclosure
The solution enables secure, centralised, electronic distribution and response capture of Financial Disclosure information.
-
ICON named by Forbes as one of the best employers in America
Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors
-
ICON announces clinical research partnership with DuPage Medical Group
Additional PMG Research site locations enhances ICON’s site and patient engagement capabilities
-
ICON sponsors industry-wide clinical trials survey to support Transforming Trials initiative
A new survey of pharmaceutical executives and professionals by ICON and Pharma Intelligence, which examines the key challenge of declining research and development (R&D) efficiency.
-
-
ICON and AMAG Pharmaceuticals honoured as Clinical Research Team of the Year
The award honoured the achievements of the team for executing a Phase III iron deficiency anaemia trial
-
ICON receives 2018 CRO Phase IV Leadership Award
ICON recognised for specialised real world evidence and late phase services.
-
ICON announces agreement with Intel
The Intel platform is an edge-to-cloud artificial intelligence (AI) solution that enables remote monitoring and continuous capture of clinical data.
